IFF INTERNATIONAL FLAVORS & FRAGRANCES INC — earnings, filings & institutional moves

Price chart

Daily historical data with per-account defaults

Latest close

$76.26

Period return

+4.10 (+5.68%)

Volume

916.2K

2026-07-21O $77.17 H $77.54 L $76.12 C $76.26MA5 $76.93MA20 $77.83MA60 $75.91MA120 $74.97

6M · 124 barsYahoo Finance · USD2026-01-22 → 2026-07-21

Recent event timeline

Filings, earnings, research, and institutional changes — newest first

View all →

2026. 08. 04.Highin 14 days
다음 실적 발표 예정
예정된 실적 발표입니다. 일정과 시장 기대치를 확인하세요.
2026. 05. 09.LowBUY2 months ago
Barclays: Overweight
US analyst rating / recommendation change.
2026. 05. 08.LowBUY3 months ago
Citigroup: Buy
US analyst rating / recommendation change.
2026. 05. 08.LowBUY3 months ago
JP Morgan: Overweight
US analyst rating / recommendation change.
2026. 05. 07.LowBUY3 months ago
Oppenheimer: Outperform
US analyst rating / recommendation change.
2026. 04. 22.LowBUY3 months ago
Oppenheimer: Outperform
US analyst rating / recommendation change.
2026. 04. 15.LowBUY3 months ago
Barclays: Overweight
US analyst rating / recommendation change.
2026. 04. 14.LowBUY3 months ago
Citigroup: Buy
US analyst rating / recommendation change.
2026. 04. 10.LowHOLD3 months ago
UBS: Neutral
US analyst rating / recommendation change.
2026. 02. 18.LowBUY5 months ago
Barclays: Overweight
US analyst rating / recommendation change.

Recent earnings

Consensus vs. actual, and revenue trend

Earnings tab →

Research actions

Consensus PT $91.58 · 17 analysts

Research tab →

AI Brief (Premium)

Automated summary from public sources · not investment advice

Brief tab →

No AI brief generated yet. You can create one from the Brief tab.

Top institutions (13F)

Ranked by position value

Institutions tab →

Company info

International Flavors & Fragrances Inc., together with its subsidiaries, manufactures and markets food, beverage, health and biosciences, scent, and complementary adjacent products in the United States, and internationally. It operates in through Taste, Food Ingredients, Health & Biosciences, and Scent segments. The Taste segment offers savory products such as soups, sauces, meat, fish, poultry, snacks; beverages consists of juice drinks, carbonated or flavored beverages, spirits; sweets comprising, bakery products, candy, cereal, chewing gum; and dairy products, such as yogurt, ice cream, cheese, and other products, as well as spices and seasoning ingredients for meat, food service, convenience, alternative protein and culinary products. The Food Ingredients segment provides natural, artificial, and plant-based specialty food ingredients; natural antioxidants and anti-microbials used for natural food preservation and shelf-life extension for beverages, cosmetic and healthcare products, pet food and feed additives; and savory solutions, such as spices, marinades, and mixtures, and inclusion products comprising combining flavorings with fruit, vegetables and other natural ingredients, as well as soy and pea protein with value-added formulations, emulsifiers and sweeteners. The Health & Biosciences segment offers enzymes, food cultures, probiotics and specialty ingredients for food and non-food applications, as well as engages in health, food biosciences, home and personal care, animal nutrition and grain processing businesses. The Scent segment creates fragrance compounds, and fragrance ingredients. International Flavors & Fragrances Inc. was incorporated in 1909 and is headquartered in New York, New York.

Quarter	Date	Time	EPS est.	EPS actual	Surprise	Rev. est.	Rev. actual	Status
—	2026. 08. 04.	After market close (AMC)	$1.12	—	—	$2.69B	—	Scheduled
FY2026 Q1	2025. 03. 31.	Time TBD	—	$-3.98	—	—	$2.84B	Reported
FY2025 Q3	2024. 09. 30.	Time TBD	—	$1.27	—	—	$8.71B	Reported
FY2025 Q2	2024. 06. 30.	Time TBD	—	$0.9	—	—	$5.79B	Reported

INTERNATIONAL FLAVORS & FRAGRANCES INC

Price chart

Recent event timeline

Recent earnings

Research actions

Top news

Key stats

Date	Firm	Analyst	Action	Rating change	Price target	Report
2026. 05. 09.	Barclays	—	Maintain	Overweight → Overweight	—	Barclays: Overweight
2026. 05. 08.	Citigroup	—	Maintain	Buy → Buy	—	Citigroup: Buy
2026. 05. 08.	JP Morgan	—	Maintain	Overweight → Overweight	—	JP Morgan: Overweight
2026. 05. 07.	Oppenheimer	—	Maintain	Outperform → Outperform	—	Oppenheimer: Outperform
2026. 04. 22.	Oppenheimer	—	Maintain	Outperform → Outperform	—	Oppenheimer: Outperform
2026. 04. 15.	Barclays	—	Maintain	Overweight → Overweight	—	Barclays: Overweight